The Global Calciphylaxis Treatment Market, accounted for US$ 1,097.7 million in 2017 and is expected to witness a CAGR of 9.6% over the forecast period (2018 – 2026).
Get PDF Brochure with Latest Insights @ https://www.coherentmarketinsights.com/insight/request-pdf/2251
Calciphylaxis is a scarce condition distinguished by aggregation or calcification of calcium in the blood vessels of patient along with the thrombosis development. This could lead to dying of cells in the fatty tissues and skin of patient, which in turn causes death. Calciphylaxis diagnosis is based on symptoms and several tests including skin biopsy, imaging studies and blood tests that confirm this condition. There is no availability of dedicated treatments for calciphylaxis. Often, the healthcare professionals emphasize to balance out the minerals within the body including phosphate and calcium that may help in this condition’s treatment. This could be attained by changing regimes of dialysis, medications, or even considering parathyroid gland surgery.
Majority surgical treatments including parathyroidectomy are commonly recommended to patients having known primary hyperparathyroidism. Although, surgical debridement for removing necrotic tissues and healthy tissue healing is used more widely, its efficiency is debated. Physicians even focus on controlling pain, good nutrition, along with supreme ulcer care, in the case of skin breakdown. Therapies of wound management for calciphylaxis consists of Hyperbaric Oxygen Therapy (HBOT) and nonsurgical wound cleansing. HBOT could be regarded as the second line of treatment, in case of non-improvement in wounds. Key players and researchers in the market are focusing on discovering efficient calciphylaxis treatment. As per the 2017 study published in the Journal of the American Society of Nephrology, deficiency of Vitamin K could result in calciphylaxis development. Moreover, as per the 2017 study published in BioMed Central Nephology Journal, supplementing Vitamin K2 for 4 weeks can remarkably cause improvement in vascular calcification.
Global Calciphylaxis Treatment Market: Key Takeaways
- The global calciphylaxis treatment market is expected to exhibit a 9.6% CAGR over the forecast period, due to increasing dialysis-associated calciphylaxis cases. As per the 2017 study by Nephrology Dialysis Transplantation Journal, the German Calciphylaxis Registry registered calciphylaxis rate of estimated 30 new cases annually in the patients of dialysis from 2006 to 2015
- On the basis of region, North America is expected to produce significant revenue share over the forecast period, due to rising demand for procedures of kidney transplantation along with increasing patients of dialysis. In 2016, as per the National Kidney Foundation, every month over 3,000 patients went through kidney transplantation within the U.S.
- Major players functioning in the global calciphylaxis treatment market are, 3M, BSN Medical, Amgen Inc., ConvaTec Inc., Smith & Nephew Plc., Medtronic Plc., Laboratoris Sanifit S.L., and others
Get Sample Report with Latest Covid19 Impact Analysis @ https://www.coherentmarketinsights.com/insight/request-sample/2251
Table of Content
Chapter 1 Industry Overview
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 Global Calciphylaxis Treatment Market Size Analysis from 2021 to 2027
11.6 COVID-19 Outbreak: Calciphylaxis Treatment Industry Impact
Chapter 2 Global Calciphylaxis Treatment Competition by Types, Applications, and Top Regions and Countries
2.1 Global Calciphylaxis Treatment (Volume and Value) by Type
2.3 Global Calciphylaxis Treatment (Volume and Value) by Regions
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.2 Regional Production Market Analysis
Chapter 4 Global Calciphylaxis Treatment Sales, Consumption, Export, Import by Regions (2016-2021)
Chapter 5 North America Calciphylaxis Treatment Market Analysis
Chapter 6 East Asia Calciphylaxis Treatment Market Analysis
Chapter 7 Europe Calciphylaxis Treatment Market Analysis
Chapter 8 South Asia Calciphylaxis Treatment Market Analysis
Chapter 9 Southeast Asia Calciphylaxis Treatment Market Analysis
Chapter 10 Middle East Calciphylaxis Treatment Market Analysis
Chapter 11 Africa Calciphylaxis Treatment Market Analysis
Chapter 12 Oceania Calciphylaxis Treatment Market Analysis
Chapter 13 South America Calciphylaxis Treatment Market Analysis
Chapter 14 Company Profiles and Key Figures in Calciphylaxis Treatment Business
Chapter 15 Global Calciphylaxis Treatment Market Forecast (2021-2027)
Chapter 16 Conclusions
Purchase This Premium Report To Access Full Information @ https://www.coherentmarketinsights.com/insight/buy-now/2251
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients to achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having an office at global financial capital in the U.S. and sales consultants in the United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies to not-for-profit organizations, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027